Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein shisa-like-2A (SHISAL2A, FAM159A) is a predicted single-transmembrane membrane adaptor protein belonging to the shisa-like (STMC6) family, marked by an N-terminal cysteine-rich domain (with six conserved cysteines) and a short C-terminal tail[2]. While the broader Shisa and Shisa-like protein family is evolutionarily conserved among metazoans and has roles in developmental signaling (notably Wnt and FGF pathway regulation) and as AMPA/GABA receptor auxiliary subunits in the nervous system, there is almost no direct experimental evidence about SHISAL2A's independent biological role, disease association, or therapeutic target potential in humans[1][2]. The family is characterized by motifs that might allow interaction with WW-domain–containing proteins such as E3 ubiquitin ligases, possibly regulating cell-surface protein sorting or degradation. SHISAL2A is not known to be a direct therapeutic target, to interact with approved drugs, or to serve as a biomarker or clinical target. Its molecular features, structure, and classification are mainly inferred from homology to other shisa-like proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein shisa-like-2A (SHISAL2A).